Rafat Abonour

This transcript has been lightly edited for style, space, and clarity. Rafat Abonour, MD: My name is Rafat Abonour. I’m a professor of clinical medicine at the University of Miami and a member of the Myeloma Sylvester Comprehensive Cancer Center and the associate director for clinical affairs. Oncology News Central (ONC): Which multiple myeloma studies at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting are you most excited about?

INTRODUCTION Primary extragonadal germ cell tumors comprise only 5% of germ cell tumors and arise most commonly in the mediastinum in adults.1 Primary mediastinal nonseminomatous germ cell tumors (PMNSGCTs), although similar in histology and cytogenetics to testicular germ cell tumors, have less response to cisplatin-based chemotherapy and are classified as poor-risk disease regardless of other factors, such as the size of the tumor, amplitude of serum tumor markers (STMs), and other factors...

Back to Journals » ClinicoEconomics and Outcomes Research » Volume 15 Authors Gertz M, Abonour R, Gibbs SN , Finkel M , Landau H, Lentzsch S, Lin G, Mahindra A, Quock T, Rosenbaum C, Rosenzweig M, Sidana S , Tuchman SA, Witteles R, Yermilov I , Broder MS Received 22 March 2023 Accepted for publication 25 August 2023 Published 11 September 2023 Volume 2023:15 Pages 673—680 DOI https://doi.org/10.2147/CEOR.S412079 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer...